Delivery Order 36F79720D0075-36C26024F0338
Award Date
4/4/24
Potential Completion Date
4/4/25
Potential Value
$11K
Federal Agency
Veterans Integrated Service Network 20
Awardee
Vifor (International) AG
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
La Vergne, TN 37086, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award by the Department of Veterans Affairs (VA) to Vifor (International) AG, a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of KORSUVA 50 MG, a medication for pruritus (itching). The contract, valued at $1,365.88, is a delivery order issued under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. It has an ultimate completion date of February 28, 2025. The contract is a firm fixed-price arrangement and does not...
The Department of Veterans Affairs (VA) awarded a $2,425.46 firm-fixed price delivery order to Vifor (International) AG, a global biotechnology company and manufacturer, to provide the pharmaceutical product Korsuva (difelikefalin) to VA facilities. This order was placed against Vifor's Federal Supply Schedule contract for Pharmaceuticals and Drugs. The delivery order has a completion date of May 8, 2024 and was awarded on April 23, 2024 without any set-aside designation. Vifor has previously...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a $2,425.46 firm-fixed-price delivery order to Vifor (International) AG, a foreign-owned for-profit pharmaceutical manufacturer, to provide the emergency medication KORSUVA (difelikefalin) to VHA's Veterans Integrated Service Network 21. This delivery order was placed against Vifor's Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The order has a performance period through May...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $1,212.73 firm-fixed price delivery order to Vifor (International) AG, a global biotechnology company, to supply DIFELIKEFALIN 50MCG/ML INJ,SOLN VIAL,1.3ML (KORSUVA) pharmaceuticals to VA facilities in Redwood City, CA. This order was placed under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. Vifor has also received previous awards from the VA, including a $23.8 million Blanket...
Vifor (International) AG was awarded a $3,638.19 delivery order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 to supply pharmaceuticals under the Pharmaceuticals and Drugs Federal Supply Schedule. The order has a completion date of April 30, 2024 and was awarded on January 31, 2024 without a set-aside designation. Vifor will provide KORSUVA, a pharmaceutical used to treat medical conditions, to VA facilities located in La Vergne,...
Vifor (International) AG has been awarded a $1,212.73 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20. This firm fixed price order, to be completed by February 29, 2024, is for pharmaceutical products to support the VA's healthcare programs serving veterans in the La Vergne, Tennessee area. No set-aside designation was applied to this order. Vifor...
This delivery order, awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 (VHA VISN 12), is for the pharmaceutical MIRCERA 50MCG/0.3ML SYRINGE, with a potential value of two hundred sixty-one dollars. The contract was awarded on December 15, 2023 to Vifor (International) AG of İsviçre under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), a multiple award schedule managed by the General Services Administration....
This is a $1,063,332.48 firm fixed price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Novartis Pharmaceuticals Corporation, a foreign-owned, for-profit manufacturer of pharmaceutical goods. The contract is for the delivery of the drug PLUVICTO and does not have a set-aside designation. The contract is associated with the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, which provides a comprehensive range of pharmaceutical and...
This is a federal contract award from the U.S. Department of Veterans Affairs (VA) to Novartis Pharmaceuticals Corporation, a foreign-owned, for-profit manufacturer of pharmaceutical goods. The contract, valued at $231,396.00, is a Delivery Order contract with a Firm Fixed Price pricing type. The contract is for the procurement of specialized medical treatments, such as cancer therapies and advanced pharmaceuticals, to support the VA's medical programs. The contract utilizes the...
This is a firm fixed-price delivery order awarded to CSL Behring L.L.C., a foreign-owned, for-profit biotherapeutics company, by the U.S. Department of Veterans Affairs (VA). The contract is part of the VA's Federal Supply Schedule (FSS) for Pharmaceuticals and Drugs (FSS-61-IB), with a ceiling value of $75,295.97. The order is for pharmaceutical products, including medications like HAEGARDA, Privigen, Hizentra, and Kcentra, to support healthcare services for veterans across different VA medical...